Table 1.

Phenotype of gastric HLA DR⁺ DCs, CD13⁺ cells and MoDCs from noninfected and H. pylori-infected subjects

	% HLA DR+a		% CD13+		% MoDCb
H. pylori status	Non-infected	Infected	Non-infected	Infected	Non-infected
n	4	3	3	3	4
CD11cc	18.6 ± 1.8%d	46.6 ± 5.0%***	5.2 ± 2.9%	6.9 ± 2.6%	96.7 ± 3.0%
CD14	14.4 ± 2.8	22.3 ± 2.1	4.1 ± 1.6	9.8 ± 2.6	2.8 ± 0.6
CD80	2.8 ± 0.6	12.8 ± 8.1	1.6 ± 0.7	0.9 ± 0.4	15.2 ± 5.8
CD83	2.0 ± 0.3	6.3 ± 2.6*	2.3 ± 1.1	4.4 ± 1.3	5.9 ± 2.1
CD86	7.5 ± 0.9	20.3 ± 3.9**	2.4 ± 1.5	5.2 ± 4.2	59.7 ± 11.8
CD206	14.5 ± 4.3	5.8 ± 0.0e	2.7 ± 2.0	0.3 ± 0.0e	86.2 ± 9.7
DC-SIGN	14.1 ± 6.3	25.1 ± 10.1	3.1 ± 1.6	5.6 ± 1.7	91.5 ± 3.9

Abbreviation: MoDC, monocyte-derived dendritic cells.

^aGastric mucosal cell subsets were enriched by MACS.

^bImmature MoDCs (day 6) were used as controls.

^cSurface markers were analyzed by FACS, with cells gated as either HLA DR^high or CD13⁺ cells.

^dMean ± s.e.m.

^en = 1

^***P<0.001;

^**P<0.01;

^*P<0.05